# Beam Therapeutics (BEAM) — News

BEAM · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/beam/news

## Recent headlines

- [Banca Mediolanum: BofA global research raises price objective to EUR 25.5 from EUR 24.5](https://www.ainvest.com/news/banca-mediolanum-bofa-global-research-raises-price-objective-eur-25-5-eur-24-5-2610) — AInvest Wire, Oct 15, 2026
  Bank of America’s global research team has raised its price objective for Banca Mediolanum (BMEDM) to EUR 25.5 from EUR 24.5, reflecting improved expectations for the Italian financial services group. The adjustment follows strong performance in 2025, during which Banca Mediolanum reported a record…
- [CEAT 2Q other income 50M rupees, +25% y/y](https://www.ainvest.com/news/ceat-2q-income-50m-rupees-25-2610) — AInvest Wire, Oct 14, 2026
- [CEAT 2Q rev. 47.6B rupees, est. 46.49B rupees](https://www.ainvest.com/news/ceat-2q-rev-47-6b-rupees-est-46-49b-rupees-2610) — AInvest Wire, Oct 14, 2026
- [CEAT 2Q net income 1.12B rupees, -40% y/y](https://www.ainvest.com/news/ceat-2q-net-income-1-12b-rupees-40-2610) — AInvest Wire, Oct 14, 2026
- [BEM holder sells 200M shrs at 6.5% discount: Terms](https://www.ainvest.com/news/bem-holder-sells-200m-shrs-6-5-discount-terms-2609) — AInvest Wire, Sep 24, 2026
  Beam Therapeutics (BEM) has announced the pricing of a public offering, with a shareholder selling 200 million shares at a 6.5% discount to the current market price. The terms of the offering have been disclosed, though use of proceeds or pricing mechanism were not included in the provided…

## Similar Stocks

- [CRSP](https://www.lighthorse.io/tickers/crsp) — CRISPR Therapeutics AG - Common Shares
- [NTLA](https://www.lighthorse.io/tickers/ntla) — Intellia Therapeutics, Inc. - Common Stock
- [EDIT](https://www.lighthorse.io/tickers/edit) — Editas Medicine, Inc. - Common Stock
- [DNLI](https://www.lighthorse.io/tickers/dnli) — Denali Therapeutics Inc. - Common Stock
- [PRME](https://www.lighthorse.io/tickers/prme) — Prime Medicine, Inc. - Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).